Skip to Content

I always try to take a practical approach to solving clients’ problems. How do we advance our client’s case to obtain the best achievable result in an efficient manner without “over-litigating” the matter? This is important especially in large cases that are more common today, where a lawyer’s time is often devoted to case management, as much as it is to developing and executing the legal strategy. Additionally, I want to know what I can do to help in-house counsel and claims personnel meet the demands placed on them to satisfy internal obligations.

Paige Sensenbrenner’s litigation practice focuses on healthcare-related cases, including pharmaceutical and medical device products liability, pharmaceutical pricing claims and medical malpractice. He also has extensive experience defending toxic tort cases and has handled cases alleging insurance fraud and accounting malpractice. Many of these claims involved class actions and complex litigation.

Paige’s practice also encompasses government relations on behalf of health care entities, insurance companies and pharmaceutical manufacturers. He testifies before government committees and performs substantive government relations work, helping craft legislation to solve a specific problem or set of problems for clients.

Paige frequently lectures on legal issues, often with a focus on the health care and pharmaceutical industries. With a deep understanding of cutting-edge genomic and genetic issues and related technology, Paige makes presentations to national groups about the use of this type of evidence in product liability claims. He also advises companies on the consequences these matters may hold for their businesses, including possible impacts on manufacturing and marketing and the need to alert employees about potential harm stemming from applications of this evolving science.

Paige’s own nursing background informs his healthcare-related legal work. He served as outside general counsel for the Louisiana Cancer Research Center, a rewarding role in which he assisted those “doing the work of the angels” by saving people’s lives.


  • Loyola University New Orleans College of Law, J.D., 1987
  • Loyola University, B.S., 1983
  • Charity Hospital School of Nursing, R.N., 1978

Bar Admissions

  • Louisiana


  • Louisiana Super Lawyers® (by Thomson Reuters) Class Actions, 2023
  • International Society of Barristers, Fellow
  • AV® Preeminent Peer Review Rated by Martindale-Hubbell
  • Best Lawyers® Lawyer of the Year - New Orleans Health Care Law, 2022
  • Best Lawyers® - Government Relations Practice, Medical Malpractice Law - Defendants, Health Care Law
  • Louisiana Super Lawyers® (by Thomson Reuters) Class Actions/Mass Torts 2014-2019, 2021-2022
  • The International Who's Who of Life Sciences Lawyers
  • Health Care Heroes, New Orleans CityBusiness, 2015
  • Best Lawyers® "Lawyer of the Year" in New Orleans – Government Relations, 2016
  • New Orleans' Top Lawyers, New Orleans Magazine, 2017, 2020
  • Best Lawyers® Lawyer of the Year in New Orleans - Medical Malpractice Law - Defendants, 2020

Professional Affiliations & Memberships

  • Federation of Defense and Corporate Counsel
  • American Bar Association
  • Louisiana State Bar Association
  • Defense Research Institute
  • Louisiana Association of Defense Counsel
  • The Committee of 100
  • Council for A Better Louisiana, Board of Directors
  • Product Liability Advisory Council
  • Current Regulatory and Liability Issues for Drug Compounding, DRI: For the Defense, Co-author (Sept. 2013)
  • Genetics and Genomics: Making the Invisible Visible, DRI: For the Defense, Co-author (Apr. 2015)
  • Representing a Danish multinational pharmaceutical company in a suit filed by the Louisiana Attorney General alleging violations of Louisiana’s Unfair Trade Practices Act with regards to insulin pricing.
  • Successfully defended an American multinational oil and gas corporation against a punitive damage case regarding a toxic tort claim alleging radiation exposure causing thyroid cancer in a jury trial.
  • Represented an American multinational pharmaceutical company against a claim in connection with allegedly defective breast implants.
  • Represented an American multinational healthcare company regarding allegedly defective dialysis solution.
  • Currently advising two retailer-owned companies that service independent retail grocers in a matter involving allegedly defective phenylephrine medications.
  • Currently representing a British-Swedish multinational pharmaceutical and biotechnology company in a matter in connection with Nexium alleging gastric cancer.